FATE
Fate Therapeutics, Inc. · Healthcare
Chief R, D Officer Bahram Valamehr sold $519K of Fate Therapeutics, Inc.
Sold$518,686
$30.23Price
17,158Shares
−9%Stake
What FATE did after the filing
- The stock from Fri, Jul 8 close, $30.01
- −3.3%
- S&P 500, same days
- +8.6%
Measured over 30 trading days, to the Aug 19 close.
Traded Thu, Jul 7. Filed Fri, Jul 8, 12:51 PM ET, during the session. Returns use the Jul 8 close and the Aug 19 close. Not investment advice.